Authors:
O'Brien, SM
Kantarjian, AM
Cortes, J
Beran, M
Koller, CA
Giles, FJ
Lerner, S
Keating, M
Citation: Sm. O'Brien et al., Results of the fludarabine and cyclophosphamide combination regimen in chronic lymphocytic leukemia, J CL ONCOL, 19(5), 2001, pp. 1414-1420
Authors:
Beran, M
Shen, Y
Kantarjian, H
O'Brien, S
Koller, CA
Giles, FJ
Cortes, J
Thomas, DA
Faderl, S
Despa, S
Estey, EH
Citation: M. Beran et al., High-dose chemotherapy in high-risk myelodysplastic syndrome - Covariate-adjusted comparison of five regimens, CANCER, 92(8), 2001, pp. 1999-2015
Citation: Ca. Koller et al., Twelve tips for developing educational multimedia in a community-based teaching hospital, MED TEACH, 22(1), 2000, pp. 7-10
Citation: Cs. Ha et al., Role of radiation therapy to the brain in leukemic patients with cranial nerve palsies in the absence of radiological findings, LEUK LYMPH, 32(5-6), 1999, pp. 497-503
Authors:
Anderson, CM
Bueso-Ramos, CE
Wallner, SA
Albitar, M
Rosenzweig, TE
Koller, CA
Citation: Cm. Anderson et al., Primary myeloid leukemia presenting concomitantly with primary multiple myeloma: Two cases and an update of the literature, LEUK LYMPH, 32(3-4), 1999, pp. 385
Authors:
Beran, M
Estey, E
O'Brien, S
Cortes, J
Koller, CA
Giles, FJ
Kornblau, S
Andreeff, M
Vey, N
Pierce, SR
Hayes, K
Wong, GC
Keating, M
Kantarjian, H
Citation: M. Beran et al., Topotecan and cytarabine is an active combination regimen in myelodysplastic syndromes and chronic myelomonocytic leukemia, J CL ONCOL, 17(9), 1999, pp. 2819-2830
Authors:
Sacchi, S
Kantarjian, HM
O'Brien, S
Cortes, J
Rios, MB
Giles, FJ
Beran, M
Koller, CA
Keating, MJ
Talpaz, M
Citation: S. Sacchi et al., Chronic myelogenous leukemia in nonlymphoid blastic phase - Analysis of the results of first salvage therapy with three different treatment approaches for 162 patients, CANCER, 86(12), 1999, pp. 2632-2641
Authors:
Koller, CA
Kantarjian, HM
Feldman, EJ
O'Brien, S
Rios, MB
Estey, E
Keating, M
Citation: Ca. Koller et al., A Phase I-II trial of escalating doses of mitoxantrone with fixed doses ofcytarabine plus fludarabine as salvage therapy for patients with acute leukemia and the blastic phase of chronic myelogenous leukemia, CANCER, 86(11), 1999, pp. 2246-2251
Authors:
Beran, M
Estey, E
O'Brien, SM
Giles, FJ
Koller, CA
Kornblau, S
Keating, M
Kantarjian, HM
Citation: M. Beran et al., Results of topotecan single-agent therapy in patients with myelodysplasticsyndromes and chronic myelomonocytic leukemia, LEUK LYMPH, 31(5-6), 1998, pp. 521-531